Elisabeth B. Wilson, MD, joins D-HH and Dartmouth’s Geisel School of Medicine as new chair of the Department of Community and Family Medicine
Dr. Wilson has accepted the role as chair and professor of the Department of Community and Family Medicine for the D-HH system and Dartmouth’s Geisel School of Medicine. She begins her role in March 2022 and will succeed Cathleen Morrow, MD as chair.
Mt. Ascutney Hospital and Health Center (MAHHC) has announced that Hannah Bianchi has been named as the new Chief Operating Officer (COO) of the Hospital.
D-HH has named Daisy Goodman, DNP, MPH, CARN-AP, APRN, CNM, as the vice chair of Research for Obstetrics and Gynecology (OB/GYN).
Responding to labor shortage, health system makes second major minimum wage adjustment in nine months
D-HH Launches Third Installment of its Virtual Roundtable Series as Effects of COVID-19 Pandemic Continue
“Heads Up: Coping Through COVID-19” is a pre-recorded series of virtual conversations featuring D-HH mental health experts, community partners and other experts offering information and tips for people of all ages
National staffing crisis, pandemic resurgence have increased local impacts; health providers ask for understanding and patience as they make the best, difficult decisions to ensure excellent care
The U.S. Food and Drug Administration (FDA) authorized the use of a third dose of the Pfizer and Moderna COVID-19 vaccines for immunocompromised people, with the third dose to be administered at least 28 days following the first two doses.
As districts in New Hampshire and Vermont prepare to reopen schools for in-person learning in a few weeks, leadership from New Hampshire’s only children’s hospital, Children’s Hospital at Dartmouth-Hitchcock has released recommendations for schools.
Dartmouth-Hitchcock Health to Require COVID-19 Vaccinations for Employees in Effort to Protect Health of Community
Effective September 30, 2021, Dartmouth-Hitchcock Health (D-HH) will require COVID-19 vaccination of employees as a condition of employment.
The Delta variant (B.1617.2), which originated in India, is now the dominant variant of COVID-19 in the United States, and is more transmissible than the original virus.